- Home
- Publications
- Publications Database
-
Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Authors
- Michael G. Aman, Mallikarjuna Rettiganti, Haikady N. Nagaraja, Jill A. Hollway, James T. McCracken, Christopher J. McDougle, Elaine Tierney, Lawrence Scahill, L. Eugene Arnold, Jessica A. Hellings, David J. Posey, Naomi B. Swiezy, Jaswinder K. Ghuman, Marco Grados, Bhavik G. Shah, Benedetto Vitiello
- Title
- Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.
- Journal
- Journal of Child and Adolescent Psychopharmacology
- Year
- 2015
- Month
- August
- Volume
- 25
- Issue
- 6
- Page(s)
- pp. 482-493.
- Full Item
- Read Full Item (New Window)
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Yes
- Scientific Validity
- Peer-Reviewed, Follow-Up
- Comments
- This a follow up study of the Research Units on Pediatric Psychopharmacology Autism Network (RUPP) (2002)
- Keywords
- Adaptive Behaviour, Adolescent / Secondary School Age, Antipsychotics, Autism, Child/Children, Intervention, Irritability, Medication, Primary / Elementary School Age, Risperidone, Side Effects
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.